Urology Times 50 Innovations Series: Active surveillance for prostate cancer


"Active surveillance is an innovation because it's truly a departure from the idea that all prostate cancers or cancer, in general, needs to be treated," says Kara L. Watts, MD.

In this installment in Urology Times®' 50th Anniversary Innovation Celebration series, Kara L. Watts, MD, discusses the emergence and increasing uptake of active surveillance as a management strategy for men with prostate cancer. Watts, a member of the Urology Times® Editorial Council, is an assistant professor of urology at Montefiore Medical Center, Bronx, New York.

Related Videos
Paul E. Dato, MD, an expert on prostate cancer
Charles Parker, MD, answers a question during a Zoom video interview
Dr Daniel Allen Hamstra
Dr Daniel Allen Hamstra
3D illustration of prostate cancer cells | Image Credit: © Dr_Microbe - stock.adobe.com
Dr Daniel Allen Hamstra
Related Content
© 2023 MJH Life Sciences

All rights reserved.